Gann Support (EP/CL): 0.11/0.09 | Resistance (TP): 0.15/0.17
*Highlighted column shows significant volume at the support or resistance area.
Moving Average Trend
Trading Signalsbeta - SUNZEN [NS]
Based on iSaham Screeners
Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
BUY (Above 0)
Solid MA Trend
Sector Trend (Long Term)
Sector Trend (Short Term)
Beat The Insti
Better Than ASB
Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.
iSaham Fair Value: -0.15
Discounted Cash Flow (DCF)5.0% Growth
Discounted Cash Flow (DCF)-45.6% Growth
Net Tangible Asset (NTA)
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
The principal activities of Sunzen Biotech Berhad are investment holding and manufacturing of animal health products. The principal activities of the subsidiaries are R&D; and commercialisation of in-feed anti bacterial products and supplements for animal health products, distribution amd marketing of animal health products. Sunzen Biotech Berhad was incorporated in Malaysia on 8 February 2005 as a public limited company. The group consists of Sunzen Biotech and wholly owned subsidiaries namely Sunzen Corporation, Sunzen LifeSciences and Sunzen Feedtech. The principle activities of the company is investment holding whilst it subsidiaries are involved in the manufacturing of animal health products focused in animal feed additive market to feed millers and livestock producers across Asian markets. The company manufactures and distributes its own brand of products mainly locally.